Global burdens of nasopharyngeal carcinoma in children and young adults and predictions to 2040.
Oral Oncol
; 155: 106891, 2024 Aug.
Article
en En
| MEDLINE
| ID: mdl-38878356
ABSTRACT
OBJECTIVES:
To investigate the epidemiological trend for nasopharyngeal carcinoma among children and young adults and the disease burden they caused. MATERIALS ANDMETHODS:
Data were collected from the Global Burden of Disease (GBD) study 2019. A comprehensive analysis was performed, with age-standardized incidence rate (ASIR), age-standardized mortality rate (ASMR), disability-adjusted life-years (DALYs) and estimated annual percentage changes (EAPC). And decomposition and frontier analyses were done. Future trends were predicted using Bayesian age-period-cohort model.RESULTS:
Globally, there were decreases in the ASIR (EAPC -0.175, 95 % confidence interval [CI] -0.352 to 0.002), ASMR (EAPC -2.681, 95 % CI -2.937 to -2.424), and age-standardized DALYs rates (EAPC -2.643, 95 % CI -2.895 to -2.391). However, the ASIR for males in global (EAPC 0.454, 95 % CI 0.302 to 0.606), Asia (EAPC 0.782, 95 % CI 0.610 to 0.954) and America (EAPC 0.448, 95 % CI 0.379 to 0.517), as well as females in European (EAPC 0.595, 95 % CI 0.479 to 0.712) and American (EAPC 0.369, 95 % CI 0.324 to 0.415), showed an increasing trend. The future ASIR per 100,000 will likely show a slight upward trend in 2020 to 2040 (increased from 0.254 to 0.284), particularly among females (increased from 0.177 to 0.206), and a continued decline in ASMR for both sexes (decreased from 0.070 to 0.061).CONCLUSIONS:
Globally, NPC in children and young adults remains a major public health issue, with the global distribution and magnitude of the burden varies markedly, highlighting the need to formulate regional and population-based policies for primary prevention.Palabras clave
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Carga Global de Enfermedades
/
Carcinoma Nasofaríngeo
Límite:
Adolescent
/
Adult
/
Child
/
Child, preschool
/
Female
/
Humans
/
Infant
/
Male
Idioma:
En
Revista:
Oral Oncol
Asunto de la revista:
NEOPLASIAS
Año:
2024
Tipo del documento:
Article